BeiGene_臺灣百濟神州有限公司
Tiếng Anh Điều kiện
R&D-Senior Scientist
10/21 Cập nhật
Toàn thời gian
Mới tốt nghiệp
Tiếng Anh Điều kiệnLương & địa điểm làm việc
Thỏa thuận
(Thường từ 40.000NTD trở lên)
台北市內湖區
Điều kiện
Yêu cầu ngôn ngữ
Tiếng Anh
聽/中等、說/中等、讀/中等、寫/中等
Kinh nghiệm
不拘
Mô tả công việc
Main roles/responsibilities
• Ability to properly follow protocols, procedures, and instruction, and document all work in notebook.
• Support the project and providing high-quality iPSCs for other research groups.
• iPSC stocks banking and management.
• Perform daily GxP laboratory maintenance tasks including ordering reagents,maintaining stocks, and aliquoting solutions, etc.
• Ensure timely completion of testing and tasks as assigned
• Demonstrated accountability and be flexible to change project objectives according to the project needs.
Job Requirement
• Master in Stem Cell Biology, Molecular Biology, Biochemistry, or related fields.
• Ability to work on weekends for iPSC cell culture, take turns to be on duty.
• Self-motivated, self-managed and willing to take multi-task and work efficiently.
• The successful candidate should have excellent communication and teamwork skills.
• 2+ year pharmaceutical or biotechnology industry experience
Technical/Skills Required
• Continuous learning and the ability to acquire new knowledge to meet job requirements. Good professionalism and professional ethics and be responsibility.
• Be able to work under pressure
• Self-motivator, hands-on, disciplined and proactive person with great team-work spirit.
Số lượng tuyển dụng
1~2人
Trình độ học vấn
碩士以上
Yêu cầu ngành học
自然科學學科類、醫藥衛生學科類、農林漁牧學科類
Giờ làm việc
週末輪班補休
Chế độ nghỉ
依公司規定
Việc Làm Gợi Ý
Laboratory Equipment Operation
New Drug Research and Experiment Planning and Execution
實驗室設備操作 新藥研發實驗規劃執行
Loại công việc
Biological Researcher
Biotechnology Research and Development Staff
Pharmaceutical Research and Development Staff
台北市信義區
生化科技研發業
BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more accessible and affordable to cancer patients worldwide. We have a commercial presence in more than 60 markets, with products treating various forms of cancer, and our broad and deep pipeline has the potential to address 80 percent of cancers by incidence.
We have grown rapidly since our founding in 2010 to more than 10,000 colleagues working on five continents, including more than 1,100 oncology researchers, one of the largest such teams in the industry. We have administrative offices in Basel, Beijing and Cambridge, U.S.
As we have grown, we have also evolved. In 2022, the company published its first Environmental, Social and Governance report and introduced “Change in the Cure,” a framework that provides a path for helping us shape a better world by advancing global health, improving access to medicines and ensuring quality in all our work. We have also introduced initiatives to improve work/life balance for our colleagues.
Today, BeiGene is a 【TOP 50 Pharmaceutical Company】 and a 【TOP 20 Oncology Company】 in 2022.
To learn more about BeiGene, please visit www.beigene.com or follow us on LinkedIn at @BeiGene
